Synopsis
0
JDMF
0
EU WC
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
ABOUT THIS PAGE
A Nomegestrol Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nomegestrol Acetate, including repackagers and relabelers. The FDA regulates Nomegestrol Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nomegestrol Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nomegestrol Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nomegestrol Acetate supplier is an individual or a company that provides Nomegestrol Acetate active pharmaceutical ingredient (API) or Nomegestrol Acetate finished formulations upon request. The Nomegestrol Acetate suppliers may include Nomegestrol Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Nomegestrol Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nomegestrol Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Nomegestrol Acetate active pharmaceutical ingredient (API) in detail. Different forms of Nomegestrol Acetate DMFs exist exist since differing nations have different regulations, such as Nomegestrol Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nomegestrol Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Nomegestrol Acetate USDMF includes data on Nomegestrol Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nomegestrol Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nomegestrol Acetate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nomegestrol Acetate Drug Master File in Korea (Nomegestrol Acetate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nomegestrol Acetate. The MFDS reviews the Nomegestrol Acetate KDMF as part of the drug registration process and uses the information provided in the Nomegestrol Acetate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nomegestrol Acetate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nomegestrol Acetate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nomegestrol Acetate suppliers with KDMF on PharmaCompass.
A Nomegestrol Acetate CEP of the European Pharmacopoeia monograph is often referred to as a Nomegestrol Acetate Certificate of Suitability (COS). The purpose of a Nomegestrol Acetate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Nomegestrol Acetate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Nomegestrol Acetate to their clients by showing that a Nomegestrol Acetate CEP has been issued for it. The manufacturer submits a Nomegestrol Acetate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Nomegestrol Acetate CEP holder for the record. Additionally, the data presented in the Nomegestrol Acetate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Nomegestrol Acetate DMF.
A Nomegestrol Acetate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Nomegestrol Acetate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Nomegestrol Acetate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nomegestrol Acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nomegestrol Acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nomegestrol Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nomegestrol Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nomegestrol Acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nomegestrol Acetate suppliers with NDC on PharmaCompass.
Nomegestrol Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nomegestrol Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nomegestrol Acetate GMP manufacturer or Nomegestrol Acetate GMP API supplier for your needs.
A Nomegestrol Acetate CoA (Certificate of Analysis) is a formal document that attests to Nomegestrol Acetate's compliance with Nomegestrol Acetate specifications and serves as a tool for batch-level quality control.
Nomegestrol Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Nomegestrol Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nomegestrol Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Nomegestrol Acetate EP), Nomegestrol Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nomegestrol Acetate USP).
LOOKING FOR A SUPPLIER?
